HemoSonics-UVA HemoSonics-UVA Cardiac Surgery Clinical Study Protocol

NCT02456467 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-10-27

No results posted yet for this study

Summary

This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.

Conditions

Sponsors & Collaborators

  • HemoSonics LLC

    collaborator INDUSTRY
  • University of Virginia

    lead OTHER

Principal Investigators

  • Danja Groves, MD · UVA Anesthesiology Faculty

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02456467 on ClinicalTrials.gov